Main container

Sarcoma di Ewing extra scheletrico: valutazione dei fattori prognostici clinico-patologici e della risposta alle terapie

Title
Sarcoma di Ewing extra scheletrico: valutazione dei fattori prognostici clinico-patologici e della risposta alle terapie
Code
RETRO-EES
Type
Osservazionale
Start Year
2022
Status
Terminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more